ArticleOrphanet journal of rare diseases2025

Perspectives on the FDA platform technology designation program for the approval of gene therapies: a Swiss multi-stakeholder exploratory interview study.

Yi Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.